Post Categories
Impact of Biomarkers on Current Parkinson’s Disease Treatment Research
July 8, 2019
About a century ago, Otto Loewi discovered in his laboratories in Graz, Austria, that nerve impulses are transmitted by chemical messengers like acetylcholine. Since…
The 6 C’s of Innovation in Customer Excellence
July 1, 2019
Although customer service is a critical component of the global economy, there is surprisingly little innovation in the field compared to the ingenuity in…
QPS Celebrating Sustained Growth in Asia
June 24, 2019
Did you know that 23.6 percent of the world’s pharmaceutical companies are now located in Asia? That’s up from 20.5 percent in 2018 –…
Conference Report: EAACI Annual Conference in Lisbon, Portugal on June 1 – 5, 2019
June 17, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS Netherlands, and EAACI Asthma Section Chair 2017-2019, lectured…
Power Women in Business Development at QPS Netherlands
June 13, 2019
Two power women currently ‘man’ the Business Development (BD) department at QPS Netherlands, in close collaboration with the Head of BD, Edwin van Vulpen,…
Inflammatory Disease Models and Biomarkers
June 10, 2019
Trained and supervised by internationally recognized experts, we have acquired skills in a variety of inflammatory disease models at QPS. Such models can be…
Accelerating Pharmaceutical Breakthroughs for CNS Disorders
June 5, 2019
Although we’ve made great progress in our understanding of the central nervous system (CNS) and the disorders that affect it, CNS drug development continues…
Skin Biopsy: A Complex Model Exploring Gene Expression
May 9, 2019
The heterogeneous presentation of clinical cases and the complex requirements by health authorities and care management contribute to making the development of innovative treatment…
QPS: Young at Heart
May 9, 2019
At QPS, we work with a team of Research Physicians, who are all young professionals pursuing a career in Drug Development and/or Clinical Pharmacology….
Meet QPS at the EAACI in Lisbon
May 9, 2019
Professor Zuzana Diamant, EAACI Asthma Section Chair (2017-2019), will chair and lecture at the EAACI (European Academy of Allergy and Clinical Immunology) symposium in…
Meet QPS at the ATS in Dallas
May 9, 2019
Professor Zuzana Diamant, MD PhD, Executive Medical and Scientific Director of Respiratory & Allergy at QPS-NL and Khalid Abd-Elaziz, MD, Principle Investigator, Associate Medical…
DDI Studies: The Final Frontier?
May 9, 2019
QPS recognizes the importance of well-conducted clinical trials on drug-drug interactions. Historically, the CYP450 interactions provided valuable information for the safe use of drugs,…
Evaluating the Costs and Benefits of COVID Lockdowns
October 24, 2022
In the wake of the economic and human costs of the COVID-19 pandemic and governments’ responses to the virus, researchers have tried to evaluate…
FDA Sanctions First Interchangeable Biosimilar Sans Switching Study
October 17, 2022
In August 2022, the Food and Drug Administration (FDA) approved Cimerli™ (ranibizumab-eqrn) as a biosimilar for Lucentis® (ranibizumab). In a time when high prescription…
Amid Polio Outbreaks Around the World, Public Health Leaders Continue to Sound the Alarm
October 10, 2022
“Polio anywhere is a risk to people everywhere.” This public health mantra gets to the root of the problem. Polio remains endemic in Afghanistan…
Lymphatic Delivery Offers Potential Perks for Kinase Inhibitors and Other Cancer Drugs
October 3, 2022
A potential new cancer drug delivery method — through the gut’s lymphatic system rather than blood vessels — could improve treatment outcomes and reduce…
Burden of Disease by Social Status
September 28, 2022
Inequality in the United States has never been more apparent, especially in the wake of the COVID-19 pandemic. In a time when higher income…
Robotic Jumper Scales Tall Buildings in a Single Bound
September 26, 2022
Not unlike a superhero leaping into the air to protect humanity, a new jumping robot can reach a height of 30 meters (100 feet),…
Introduction Real-world evidence (RWE) is accelerating drug development by using routinely collected patient health data, known as real-world data (RWD), to deliver insights beyond…
Introduction Researchers are developing novel, safer treatments for cancer, but bringing new oncology therapies to market is challenging. This white paper will examine the…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
NEWARK, Del.—(BUSINESS WIRE)—QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalytics and clinical trials, is celebrating its 30-year anniversary in…
NEWARK, Del.—(BUSINESS WIRE)—QPS India, a subsidiary of QPS Holdings, LLC (QPS), a GLP/GCP-compliant global full-service Contract Research Organization, has achieved another significant milestone by…
TAIPEI, Taiwan—(BUSINESS WIRE)—QPS, a leading global contract research organization (CRO) specializing in preclinical and clinical drug development services, is pleased to announce the expansion…
